Correlation Between Enveric Biosciences and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Altamira Therapeutics, you can compare the effects of market volatilities on Enveric Biosciences and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Altamira Therapeutics.
Diversification Opportunities for Enveric Biosciences and Altamira Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enveric and Altamira is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Altamira Therapeutics
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Altamira Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Enveric Biosciences is 1.31 times less risky than Altamira Therapeutics. The stock trades about -0.53 of its potential returns per unit of risk. The Altamira Therapeutics is currently generating about -0.23 of returns per unit of risk over similar time horizon. If you would invest 57.00 in Altamira Therapeutics on August 24, 2024 and sell it today you would lose (15.00) from holding Altamira Therapeutics or give up 26.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enveric Biosciences vs. Altamira Therapeutics
Performance |
| Timeline |
| Enveric Biosciences |
| Altamira Therapeutics |
Enveric Biosciences and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and Altamira Therapeutics
The main advantage of trading using opposite Enveric Biosciences and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |